Table 2.

The treatment plan and QA results of 12 SRS/SBRT patient cases

Case No	Treatment Site	Fractions	Prescription Dose (Gy)	Treatment Technique	Energy	Volume Size (cc)	Conformity Index	Gradient Index	Max Dose (Gy)	Point Dose Difference	Gamma $3\%/3 \text{mm}$	Gamma $3\%/1 \text{mm}$
1	Intracranial, Left Temporal	1	16	RapidArc	6X FFF	20.1	0.96	3.78	19.75	$-0.1\%$	100.0%	98.9%
2	Intracranial, Right Mid Cranial Fossa	3	10	RapidArc	6X FFF	61.8	1.10	3.70	35.16	$-2.1\%$	99.9%	90.8%
3	Intracranial, GBM	4	32	RapidArc	6X FFF	71.0	0.93	4.27	39.95	1.7%	100.0%	99.4%
4	Spine, L2	1	18	RapidArc	10X FFF	54.0	1.02	4.90	22.32	$-0.5\%$	99.2%	91.0%
5	Spine, T5 Epidural	1	18	IMRT	6X FFF	14.4	1.01	4.09	20.39	$-0.9\%$	99.3%	86.6%
6	Spine, C2‐C3	1	16	RapidArc	6X FFF	26.1	1.02	3.83	17.78	0.8%	100.0%	99.5%
7	Pancreas	5	35	IMRT	10X FFF	46.2	1.02	5.21	36.23	0.1%	100.0%	98.1%
8	Liver	5	35	RapidArc	10X FFF	239.8	1.00	3.58	39.11	2.1%	99.6%	87.0%
9	Left Adrenal	5	35	RapidArc	6X FFF	12.8	1.00	4.38	37.63	1.2%	97.3%	80.9%
10	Lung, Right Upper Lobe	4	48	RapidArc	6X FFF	17.8	0.98	3.45	52.33	2.6%	99.4%	97.9%
11	Lung, Left Lower Lobe	4	48	IMRT	6X FFF	60.7	1.01	3.89	56.47	$-1.8\%$	98.5%	94.0%
12	Lung, Right Upper Lobe	4	48	RapidArc	6X FFF	22.8	0.99	4.62	51.89	$-2.2\%$	99.4%	92.2%